Article info
PDFTherapeutics
Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease
Citation
Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease
Publication history
- First published November 1, 2002.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by the ACP-ASIM and BMJ Publishing Group for Evidence-Based Medicine and by the ACP-ASIM for portions reproduced from ACP Journal Club